Adaptive therapy to circumvent drug resistance to tyrosine kinase inhibitors in cancer: is it clinically relevant?
Introduction: Cancer is highly adaptable and is constantly evolving against current targeted therapies such as tyrosine kinase inhibitors. Despite advances in recent decades, the emergence of drug resistance to tyrosine kinase inhibitors constantly hampers therapeutic efficacy of cancer treatment. C...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Published: |
Taylor and Francis
2022
|
| Online Access: | http://psasir.upm.edu.my/id/eprint/100126/ https://www.tandfonline.com/doi/full/10.1080/14737140.2022.2147671 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|